- Q2 2026 revenue more than doubled year-over-year to
$34.0 million . - Net loss of
$5.1 million , representing a 20% year-over-year improvement, including a$1.9 million non-cash impact from the increase in fair value related to the warrant exchange. Net loss improved 50% excluding the impact of the warrant exchange. - Increasing 2026 revenue outlook to at least
$140.0 million , reiterating targets for net loss below$10.0 million , and positive non-GAAP Adjusted EBITDA of at least$4 million .
Revenue for the second quarter of 2026 was
Q2 2026 Financial Highlights
- Record revenue of
$34.0 million , up 19% sequentially and 2.3x year-over-year (YoY). - Gross profit of
$9.3 million , up$8.0 million and 593% YoY. - Delivered GAAP gross margin of 27%, improving from 20% in Q1 2026.
- Net loss attributable to common stockholders of
$5.1 million , a$1.3 million improvement YoY. Net loss adjusted for the$1.9 million Warrant Modification was$3.2 million . - Non-GAAP Adjusted EBITDA of
($1.0) million , a 53% or$1.1 million improvement YoY.
“Amprius delivered another robust quarter, with revenue growing 2.3x year over year and gross margin expanding to 27%,” said
Reconciliations of GAAP net loss to non-GAAP Adjusted net loss and non-GAAP Adjusted EBITDA are provided in the financial schedules that are part of this press release. An explanation of these non-GAAP financial measures is also included below under the heading “Non-GAAP Financial Measures.”
Quarterly Financial Comparison
$ in millions | ||||
Metric | Q2 2026 | Q2 2025 | Delta | Improvement |
Revenue | 34.0 | 15.1 | 19.0 | 126% |
Gross Profit | 9.3 | 1.3 | 8.0 | 593% |
% Margin | 27% | 9% |
|
|
GAAP Net Loss | (5.1) | (6.4) | 1.3 | 20% |
% Margin | (15%) | (42%) |
|
|
Non-GAAP Adjusted Net Loss | (3.2) | (6.4) | 3.2 | 50% |
% Margin | (9%) | (42%) |
|
|
Non-GAAP Adjusted EBITDA | (1.0) | (2.1) | 1.1 | 53% |
% Margin | (3%) | (14%) |
|
|
Business Highlights
- Established multi-year supply agreement starting in 2027 with Stark Future, a
Barcelona -based manufacturer of electric motorcycles, representing a total revenue opportunity exceeding$100 million - Awarded a
$24.0 million order from a major European drone developer for SiCore cylindrical cells - Supplied Redwire, a leading aerospace and defense technology company, with SiCore cells for the Stalker Block 30, a long-range intelligence surveillance and reconnaissance drone
- Advanced the
Fremont, California pilot line expansion partially funded by the Defense Innovation Unit, by initiating installation activities of about 40% of the production tools - Expanded the Company’s network of contract manufacturing partners in
South Korea , enhancing the Company’s cell production capacity - Adding pack partners, enhancing the Company’s ability to scale without adding direct sales headcount
Updated 2026 Financial Outlook
- Total revenue is now expected to be at least
$140 million , raised from at least$130 million - Gross margin guidance is now expected to be at least 28%, raised from at least 25%
- Net loss is now expected to be less than
$10 million , accounting for the$1.9 million non-cash fair value charge impact of the Warrant Exchange - Net loss per share is now expected to be under
$0.08 , accounting for the$1.9 million non-cash fair value charge impact of the Warrant Exchange
Reiterating targets:
- Adjusted EBITDA is expected to be at least
$4.0 million - Capital expenditure is expected to be under
$10.0 million
The Company's 2026 outlook assumes depreciation and amortization of
Amprius’ CFO
Conference Call and Webcast Notification
A conference call with
Shareholders and other interested parties may call 866-424-3442 (domestic) or +1 201-689-8548 (international) and reference conference ID “13761698” to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast here and hosted at the Investor Relations section of Amprius’ website, ir.amprius.com.
Following the live event, an archived version of the webcast will be available on Amprius’ website for convenient on-demand replay. A copy of this press release is posted in the Investor Relations section on Amprius’ website.
About
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, each as amended, including Amprius’ expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “will” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the ability of
Non-GAAP Financial Measures
To supplement our financial results presented on a basis in conformity with generally accepted accounting principles in
Management believes that these non-GAAP financial measures reflect our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of ongoing operating results or that may be infrequent and/or unusual in nature. We exclude the non-cash impact of the increase in fair value related to the warrant exchange, as the exchange of warrants for common shares is not related to our ongoing operations. We exclude the operating costs for our former facility in
Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating our operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies. In this press release, we provided reconciliations of non-GAAP net loss and non-GAAP Adjusted EBITDA to GAAP net loss, the most directly comparable GAAP financial measure.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except share and par value data) | |||||||
|
| ||||||
ASSETS |
|
|
| ||||
Current assets: |
|
|
| ||||
Cash and cash equivalents | $ | 74,517 |
|
| $ | 90,465 |
|
Accounts receivable, net |
| 40,650 |
|
|
| 23,737 |
|
Inventories |
| 11,510 |
|
|
| 6,735 |
|
Prepaid expenses and other current assets |
| 4,907 |
|
|
| 5,500 |
|
Total current assets |
| 131,584 |
|
|
| 126,437 |
|
Non-current assets: |
|
|
| ||||
Property, plant and equipment, net |
| 11,710 |
|
|
| 9,680 |
|
Operating lease right-of-use assets, net |
| 5,826 |
|
|
| 19,518 |
|
Other assets |
| 63 |
|
|
| 1,256 |
|
Total assets | $ | 149,183 |
|
| $ | 156,891 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
| ||||
Current liabilities: |
|
|
| ||||
Accounts payable | $ | 9,760 |
|
| $ | 6,700 |
|
Accrued and other current liabilities |
| 4,259 |
|
|
| 3,666 |
|
Deferred grant |
| 2,738 |
|
|
| 2,738 |
|
Deferred revenue |
| 413 |
|
|
| 100 |
|
Operating lease liabilities |
| 1,181 |
|
|
| 4,665 |
|
Total current liabilities |
| 18,351 |
|
|
| 17,869 |
|
Non-current liabilities: |
|
|
| ||||
Operating lease liabilities |
| 5,196 |
|
|
| 35,207 |
|
Total liabilities |
| 23,547 |
|
|
| 53,076 |
|
Commitments and contingencies |
|
|
| ||||
Stockholders’ equity: |
|
|
| ||||
Preferred stock; |
| — |
|
|
| — |
|
Common stock; |
| 14 |
|
|
| 13 |
|
Additional paid-in capital |
| 352,157 |
|
|
| 322,156 |
|
Accumulated other comprehensive income |
| 23 |
|
|
| 4 |
|
Accumulated deficit |
| (226,558 | ) |
|
| (218,358 | ) |
Total stockholders’ equity |
| 125,636 |
|
|
| 103,815 |
|
Total liabilities and stockholders’ equity | $ | 149,183 |
|
| $ | 156,891 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except share and per share data) | ||||||||||||||||
|
| Three months ended June 30, |
| Six months ended June 30, | ||||||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||||||
Revenue |
| $ | 34,032 |
|
| $ | 15,067 |
|
| $ | 62,568 |
|
| $ | 26,351 |
|
Cost of revenue |
|
| 24,752 |
|
|
| 13,727 |
|
|
| 47,548 |
|
|
| 27,372 |
|
Gross profit (loss) |
|
| 9,280 |
|
|
| 1,340 |
|
|
| 15,020 |
|
|
| (1,021 | ) |
Gross margin |
|
| 27 | % |
|
| 9 | % |
|
| 24 | % |
|
| (4 | )% |
Operating expenses: |
|
|
|
|
|
|
|
| ||||||||
Research and development |
|
| 4,099 |
|
|
| 2,162 |
|
|
| 7,898 |
|
|
| 4,165 |
|
Selling, general and administrative |
|
| 9,479 |
|
|
| 5,991 |
|
|
| 18,107 |
|
|
| 11,298 |
|
Total operating expenses |
|
| 13,578 |
|
|
| 8,153 |
|
|
| 26,005 |
|
|
| 15,463 |
|
Loss from operations |
|
| (4,298 | ) |
|
| (6,813 | ) |
|
| (10,985 | ) |
|
| (16,484 | ) |
Other income, net |
|
| 1,144 |
|
|
| 443 |
|
|
| 2,785 |
|
|
| 743 |
|
Net loss |
|
| (3,154 | ) |
|
| (6,370 | ) |
|
| (8,200 | ) |
|
| (15,741 | ) |
Increase in net loss due to warrant modification |
|
| (1,921 | ) |
|
| — |
|
|
| (1,921 | ) |
|
| — |
|
Net loss attributable to common stockholders |
| $ | (5,075 | ) |
| $ | (6,370 | ) |
| $ | (10,121 | ) |
| $ | (15,741 | ) |
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
| ||||||||
Basic and diluted |
|
| 143,469,187 |
|
|
| 121,783,506 |
|
|
| 140,226,126 |
|
|
| 119,854,678 |
|
Net loss per share of common stock: |
|
|
|
|
|
|
|
| ||||||||
Basic and diluted |
| $ | (0.04 | ) |
| $ | (0.05 | ) |
| $ | (0.07 | ) |
| $ | (0.13 | ) |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) | |||||||
| Six months ended | ||||||
| 2026 |
| 2025 | ||||
Cash flows from operating activities: |
|
|
| ||||
Net loss | $ | (8,200 | ) |
| $ | (15,741 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| ||||
Stock-based compensation |
| 4,599 |
|
|
| 3,728 |
|
Depreciation and amortization |
| 1,512 |
|
|
| 1,961 |
|
Loss on termination of lease |
| 166 |
|
|
| — |
|
Write-down of property, plant and equipment |
| 77 |
|
|
| — |
|
Non-cash operating lease expense |
| 928 |
|
|
| 2,571 |
|
Gain on disposal of property, plant and equipment |
| (355 | ) |
|
| — |
|
Other non-cash items |
| (22 | ) |
|
| 818 |
|
Changes in operating assets and liabilities: |
|
|
| ||||
Accounts receivable, net |
| (16,843 | ) |
|
| (6,005 | ) |
Inventories |
| (4,774 | ) |
|
| 2,240 |
|
Prepaid expenses and other current assets |
| 594 |
|
|
| (911 | ) |
Other assets |
| (11 | ) |
|
| 20 |
|
Accounts payable |
| 2,501 |
|
|
| (3,809 | ) |
Accrued and other current liabilities |
| 288 |
|
|
| (758 | ) |
Deferred revenue |
| 312 |
|
|
| (798 | ) |
Operating lease liabilities |
| (20,898 | ) |
|
| (1,707 | ) |
Net cash used in operating activities |
| (40,126 | ) |
|
| (18,391 | ) |
Cash flows from investing activities: |
|
|
| ||||
Purchase of property, plant and equipment |
| (2,799 | ) |
|
| (1,629 | ) |
Proceeds from the disposal of property, plant and equipment |
| 355 |
|
|
| — |
|
Net cash used in investing activities |
| (2,444 | ) |
|
| (1,629 | ) |
Cash flows from financing activities: |
|
|
| ||||
Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net |
| — |
|
|
| 18,195 |
|
Proceeds from exercise of warrants |
| 14,182 |
|
|
| — |
|
Proceeds from exercise of stock options |
| 11,221 |
|
|
| 1,066 |
|
Net cash provided by financing activities |
| 25,403 |
|
|
| 19,261 |
|
Net decrease in cash, cash equivalents and restricted cash equivalents |
| (17,167 | ) |
|
| (759 | ) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents |
| 19 |
|
|
| (7 | ) |
Cash, cash equivalents and restricted cash equivalents, beginning of period |
| 91,921 |
|
|
| 56,411 |
|
Cash, cash equivalents and restricted cash equivalents, end of period | $ | 74,773 |
|
| $ | 55,645 |
|
|
|
|
| ||||
Reconciliation of cash, cash equivalents and restricted cash equivalents shown on the condensed consolidated balance sheets: |
|
|
| ||||
Cash and cash equivalents | $ | 74,517 |
|
| $ | 54,189 |
|
Restricted cash equivalents included in prepaid expenses and other current assets |
| 200 |
|
|
| 200 |
|
Restricted cash equivalents included in other assets |
| 56 |
|
|
| 1,256 |
|
Total cash, cash equivalents and restricted cash equivalents | $ | 74,773 |
|
| $ | 55,645 |
|
GAAP TO NON-GAAP RECONCILIATION OF NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS TO ADJUSTED EBITDA (Unaudited, in thousands) | ||||||||||||||||||||
|
| Three months ended |
| Six months ended |
|
| ||||||||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 |
| Outlook FY26 | ||||||||||
Net loss attributable to common stockholders |
| $ | (5,075 | ) |
| $ | (6,370 | ) |
| $ | (10,121 | ) |
| $ | (15,741 | ) |
| $ | (10,000 | ) |
Increase in net loss due to warrant modification |
|
| 1,921 |
|
|
| — |
|
|
| 1,921 |
|
|
| — |
|
|
| 1,921 |
|
Non-GAAP adjusted net loss |
|
| (3,154 | ) |
|
| (6,370 | ) |
|
| (8,200 | ) |
|
| (15,741 | ) |
|
| (8,079 | ) |
Depreciation and amortization |
|
| 751 |
|
|
| 1,018 |
|
|
| 1,512 |
|
|
| 1,961 |
|
|
| 4,700 |
|
Stock-based compensation |
|
| 2,541 |
|
|
| 1,906 |
|
|
| 4,599 |
|
|
| 3,728 |
|
|
| 8,300 |
|
Gain on sale of equipment, net |
|
| — |
|
|
| — |
|
|
| (278 | ) |
|
| — |
|
|
| — |
|
|
| — |
|
|
| 1,707 |
|
|
| 1,216 |
|
|
| 3,459 |
|
|
| — |
| |
Interest and foreign exchange |
|
| (1,144 | ) |
|
| (389 | ) |
|
| (1,630 | ) |
|
| (689 | ) |
|
| (1,000 | ) |
Adjusted EBITDA |
| $ | (1,006 | ) |
| $ | (2,128 | ) |
| $ | (2,781 | ) |
| $ | (7,282 | ) |
| $ | 3,921 |
|
We define non-GAAP adjusted EBITDA as net loss attributable to common stockholders before interest, taxes, depreciation and amortization, stock-based compensation expense, the non-cash impact of the increase in fair value related to the warrant exchange and other items, which occur from time to time and which we do not believe are indicative of our core operating results. | ||||||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260804904743/en/
Investors
949-574-3860
IR@amprius.com
Media
949-574-3860
Amprius@Gateway-grp.com
Source: